Successfully reported this slideshow.
Rush Oncology Update, 2005
April 9, 2005
Le Meridien Chicago
521 N. Rush St. at Michigan Avenue
Chicago, IL 60611
Sponsore...
Program
7:00 - 8:00 a.m. Breakfast
8:00 - 8.10 a.m. Welcome - Dr. Philip Bonomi,
Director, Section of Hematology/
Oncology...
Objectives
Upon completion of this CME activity, participants
will be able to:
1. Describe latest therapeutic strategies t...
COURSE DIRECTORS
Pam Khosla, M.D.
Assistant Professor of Medicine
Rush University Medical Center
1725 West Harrison Street...
Pam Khosla, M.D.
Assistant Professor of Medicine
Rush University Medical Center
Chicago, IL
Mark Sliwkowski, PhD
Director,...
commercial interest (including but not limited to
pharmaceutical companies, biomedical device
manufacturers, or other corp...
Grant/Research Support: Aventis, Johnson &
Johnson
Consultant: Aventis
Mark Sliwkowski, PhD
Major Stock Holder: Employee a...
Rush University Medical Center
Section of Medical Oncology
1725 West Harrison Street, Suite 821
Chicago, IL 60612
Phone # ...
Registration Form
Rush Oncology Update, 2005
April 9, 2005 – Rush University Medical Center
One registration per form. Pho...
By FAX:
Fax completed registration form to the
attention of Lakshmi Venugopal / Cynthia
Bell:
312-563-4144
Online:
Web Bas...
Upcoming SlideShare
Loading in …5
×

Rush Oncology Update, 2005

558 views

Published on

  • Be the first to comment

Rush Oncology Update, 2005

  1. 1. Rush Oncology Update, 2005 April 9, 2005 Le Meridien Chicago 521 N. Rush St. at Michigan Avenue Chicago, IL 60611 Sponsored for Continuing Medical Education Credit by Rush University Medical Center
  2. 2. Program 7:00 - 8:00 a.m. Breakfast 8:00 - 8.10 a.m. Welcome - Dr. Philip Bonomi, Director, Section of Hematology/ Oncology, Rush University Medical Center 8:10 - 8:55 a.m Dr. Alan Venook: Advances in Colorectal Cancer 8:55 - 9:40 a.m. Dr. Melody Cobleigh: Molecular Assessment of Prognosis in Breast Cancer 9:40 - 10:25 a.m. Dr.Joseph Bailes: Oncology Health Policy: 2005 10:25 – 10:35 a.m. Panel Q & A 10:35 – 10:45 a.m. Break 10:45 – 11:10 a.m. Dr. Sefer Gezer: Cancer and Thrombosis: The New Antithrombotic Agents 11:10 – 11:35 a.m. Dr. Pam Khosla GIST: New Recommendations 11:35 – 12:00 p.m. Dr. Lydia Usha Update on Hereditary Breast and Ovarian Cancer 12:00 – 12:10 p.m. Panel Q & A 12:10 – 1:10 p.m. Lunch 1:10 – 2:10 p.m. KEYNOTE SPEAKER Dr.Mark Sliwkowski: Targeting Activated HER2 in Solid Tumors 2:10 – 2:55 p.m. Dr.Richard Gralla: Supportive Care in Oncology 2:55 – 3:40 p.m. Dr. Philip Bonomi: Targeted Therapy in Lung Cancer 3:40 -3:50 p.m. Panel Q & A 3:50 – 4:00 p.m. Dr. Pam Khosla Closing Remarks Audience This course is designed for treating and research physicians and nurses interested in the treatment of cancers. Non-physician caregivers and persons with diseases of malignant solid tumors will also be welcome at the symposium.
  3. 3. Objectives Upon completion of this CME activity, participants will be able to: 1. Describe latest therapeutic strategies to maximize beneficial effects of systemic therapy in patients with solid tumors. 2. Discuss promising investigational therapeutic regimens that are in development for the treatment of solid tumors. 3. Summarize recent advances in supportive care of oncology patients. 4. Evaluate the implications of the new Medicare billing changes as they pertain to treatment of oncology patients. Accreditation Rush University Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Rush University Medical Center designates this educational activity for a maximum of 7.0 credit(s) of Category 1 credit(s) toward the AMA Physicians’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.
  4. 4. COURSE DIRECTORS Pam Khosla, M.D. Assistant Professor of Medicine Rush University Medical Center 1725 West Harrison Street, Suite 821 Chicago, IL 60612 Philip Bonomi, MD Alice Pirie Wirtz Professor of Medical Oncology Director , Division of Hematology-Oncology Rush University Medical Center, 1725 West Harrison Street, Suite 821 Chicago, IL 60612 FACULTY Joseph Bailes, MD Co-Chair, ASCO Govt. Relations Council ASCO Alexandria, VA Philip D. Bonomi, MD Alice Pirie Wirtz Professor of Medical Oncology Director, Division of Hematology-Oncology Rush University Medical Center, Chicago, IL Melody A. Cobleigh, MD Maria Albanese Professor of Medicine Associate Director – Section of Oncology Rush University Medical Center Chicago, IL Sefer Gezer, MD Associate Professor of Medicine Rush University Medical Center Chicago, IL Richard Gralla, M.D. President, Multinational Association of Supportive Care in Cancer New York, NY
  5. 5. Pam Khosla, M.D. Assistant Professor of Medicine Rush University Medical Center Chicago, IL Mark Sliwkowski, PhD Director, Staff Scientist, Molecular Oncology Genentech South San Francisco, CA Lydia Usha, MD Assistant Professor of Medicine Rush University Medical Center Chicago, IL Alan Venook, MD Professor of Clinical Medicine UCSF Cancer Center San Francisco, CA Unapproved Uses of Drugs/Devices In accordance with requirements of the FDA, the audience is advised that information presented in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA approved package insert for each drug/device for full prescribing/utilization information. Rush University Medical Center – Office of Continuing Medical Education CME Faculty Disclosure Statement and FDA Approved Drug and Devices Assurance Statement It is the policy of the Rush University Medical Center Office of Continuing Medical Education to ensure that its CME activities are independent, free of commercial bias and beyond the control of persons or organizations with an economic interest in influencing the content of CME. Everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any
  6. 6. commercial interest (including but not limited to pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic) within the preceding 12 months which creates a conflict of interest for the person directing an educational activity. Conflicts of interest must be resolved by the CME Course Director in consultation with the Office of Continuing Medical Education prior to the participation of the faculty member in the development or presentation of course content. Faculty Disclosures Joseph S. Bailes, MD None Philip D. Bonomi, MD Grant/Research Support: Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Human Genome Science, Pfizer, Astra Zeneca, Genentech, Cell Therapeutics Inc Consultant: Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Human Genome Science, Pfizer, Astra Zeneca, Genentech, Cell Therapeutics Inc Speakers’ Bureau: Genentech, Astra Zeneca, GlaxoSmithKline, Eli Lilly and Company. Melody Cobleigh, MD Grant/Research Support: Genomic Health Consultant: Genomic Health Speakers’ Bureau: Genomic Health Sefer Gezer, MD None Richard J. Gralla, MD Grant/Research Support: Merck, GlaxoSmithKline Consultant: GlaxoSmithKline, Helsinn, Merck, MGI Pharma Pam Khosla, MD
  7. 7. Grant/Research Support: Aventis, Johnson & Johnson Consultant: Aventis Mark Sliwkowski, PhD Major Stock Holder: Employee and Stockholder of Genentech; Spouse also is an employee and stockholder of Genentech. Lydia Usha, MD Speakers’ Bureau: Myriad Genetic Laboratories Alan P. Venook, MD Grant/Research Support: Amgen, Pfizer Consultant: Genentech Speakers’ Bureau: Roche, Sanofi-Synthelabo, Genentech, Pfizer Registration Information There is no registration fee for this course. Complete and return the registration form to : Rush University Medical Center, Section of Medical Oncology, 1725 West Harrison Street, Suite 821, Chicago, Illinois 60612. A CME Certificate will be provided at a nominal cost of $25.00/ certificate. Web site address: www.rushoncologyupdate.com Location The program will be held at Le Meridien Chicago, 521 N. Rush St at Michigan Avenue, Chicago, IL 60611. Discounted Valet Parking Rate is available at the hotel for all the attendees. A limited number of rooms are available at group rate of $159.00 per night for single or double occupancy, plus 14.9% room tax is offered at the hotel. Lodging will be at your own expense. For further information:
  8. 8. Rush University Medical Center Section of Medical Oncology 1725 West Harrison Street, Suite 821 Chicago, IL 60612 Phone # (312) 563-4502 FAX # (312) 942-3192 Grant Acknowledgements The Division of Hematology/Oncology and Rush University Medical Center acknowledges unrestricted educational grants for this program from Abraxis, Amgen, Astra Zeneca, Aventis, Bristol-Myers Squibb, Genomic Health Inc., Genentech, GlaxoSmithKline, , Eli Lilly and Company, MGI Pharma, Novartis, Ortho Biotech Products, L.P., Pfizer, Roche, Sanofi-Synthelabo, Schering-Plough. This educational program would not be possible without the support of our industry partners. Please be sure to visit their exhibits during the breakfast and the breaks.
  9. 9. Registration Form Rush Oncology Update, 2005 April 9, 2005 – Rush University Medical Center One registration per form. Photocopies accepted. Last Name First Name Degree Home Address City State Zip Home Telephone Work Telephone Institution Institution Address City State Zip Department Specialty/Position E-Mail Three ways to Register: By Mail: Mail completed registration form to: Rush University Medical Center Attn: Lakshmi Venugopal /Cynthia Bell Section of Medical Oncology 1725 West Harrison Street, Suite 821 Chicago, IL 60612
  10. 10. By FAX: Fax completed registration form to the attention of Lakshmi Venugopal / Cynthia Bell: 312-563-4144 Online: Web Based Registration address: www.rushoncologyupdate.com

×